首页> 外文期刊>Clinical infectious diseases >Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States.
【24h】

Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States.

机译:在美国引入肺炎球菌结合疫苗后,肺炎球菌脑膜炎的流行病学改变。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Although hospitalizations due to invasive pneumococcal disease decreased after routine vaccination of young children with a 7-valent pneumococcal conjugate vaccine (PCV7) began in 2000, information on the trends in pneumococcal meningitis is limited. METHODS: We estimated national trends in rates of hospitalization for pneumococcal meningitis, using data from the Nationwide Inpatient Sample, 1994-2004. Pneumococcal meningitis cases and deaths were identified on the basis of the International Classification of Diseases, Ninth Edition, Clinical Modification coded primary discharge diagnosis, and rates were calculated using US Census data as denominators. The year 2000 was considered to be a transition year, and the average annualized rate after PCV7 introduction (2001-2004) was compared with that during the baseline years (1994-1999). RESULTS: During 1994-2004, there were 21,396 hospitalizations and 2684 deaths (12.5%) due to pneumococcal meningitis in the United States. In children aged < 2 years, the average annualized rates of pneumococcal meningitis hospitalizations per 100,000 population decreased from 7.7 in 1994-1999 to 2.6 in 2001-2004 (change, -66.0%; 95% confidence interval [CI], -73.5% to -56.3%). Among children aged 2-4 years, the hospitalization rate decreased from 0.9 to 0.5 per 100,000 (change, -51.5%; 95% CI, -66.9% to -28.9%). Average rates also decreased by 33.0% (95% CI, -43.4% to -20.9%) among adults aged > or = 65 years. After PCV7 introduction (2001-2004), an estimated 1822 and 573 pneumococcal meningitis hospitalizations were prevented in persons aged < 5 years and > or = 65 years, respectively. Overall, an estimated 3330 pneumococcal meningitis hospitalizations and 394 deaths were prevented in persons of all ages during 2001-2004 in the United States. CONCLUSION: After implementation of routine childhood vaccination with PCV7, hospitalizations for pneumococcal meningitis decreased significantly for both children and adults. Most pneumococcal meningitis cases now occur among adults.
机译:背景:尽管从2000年开始对7价肺炎球菌结合疫苗(PCV7)进行常规疫苗接种后,由于侵袭性肺炎球菌疾病导致的住院治疗有所减少,但有关肺炎球菌脑膜炎趋势的信息仍然有限。方法:我们使用全国住院患者样本(1994-2004年)的数据估算了肺炎球菌性脑膜炎住院率的全国趋势。肺炎球菌性脑膜炎的病例和死亡是根据《国际疾病分类》第九版,临床修改编码的初次出院诊断确定的,并以美国人口普查数据为分母来计算发病率。 2000年被视为过渡年,将引入PCV7之后(2001-2004年)的平均年化率与基准年(1994-1999年)的年化率进行了比较。结果:在1994-2004年期间,美国有21,396例因肺炎球菌性脑膜炎住院治疗,死亡2684例(12.5%)。在2岁以下的儿童中,每10万人口中肺炎球菌脑膜炎的平均每年住院率从1994-1999年的7.7下降到2001-2004年的2.6(变化,-66.0%; 95%置信区间[CI],-73.5%至-56.3%)。在2-4岁的儿童中,住院率从每10万人中的0.9降至0.5(变化为-51.5%; 95%CI为-66.9%至-28.9%)。在65岁以上的成年人中,平均发病率也下降了33.0%(95%CI,-43.4%至-20.9%)。在引入PCV7之后(2001-2004年),分别在<5岁和>或= 65岁的人群中分别预防了1822和573例肺炎球菌性脑膜炎住院。总体而言,在2001年至2004年期间,美国所有年龄段的人群中,估计有3330例肺炎球菌性脑膜炎住院和394例死亡被预防。结论:在常规儿童期接种PCV7疫苗后,儿童和成人的肺炎球菌性脑膜炎住院治疗均明显减少。现在大多数肺炎球菌性脑膜炎病例都发生在成年人中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号